151 related articles for article (PubMed ID: 17565931)
1. Effect of ocular compression on intraocular penetration of systemic ofloxacin.
Ugurbas SH; Can M; Koksal M; Dincel A; Bozkurt A; Bayar B
Adv Ther; 2007; 24(2):394-401. PubMed ID: 17565931
[TBL] [Abstract][Full Text] [Related]
2. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes.
Oztürk F; Kurt E; Inan UU; Kortunay MC; Ilker SS; Başci NE; Bozkurt A
Int J Pharm; 2000 Aug; 204(1-2):91-5. PubMed ID: 11011990
[TBL] [Abstract][Full Text] [Related]
3. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous.
Yalvac IS; Basci NE; Bozkurt A; Duman S
J Cataract Refract Surg; 2003 Mar; 29(3):487-91. PubMed ID: 12663011
[TBL] [Abstract][Full Text] [Related]
4. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Retina; 1998; 18(6):521-5. PubMed ID: 9869460
[TBL] [Abstract][Full Text] [Related]
5. The effect of long-term use and inflammation on the ocular penetration of topical ofloxacin.
Oztürk F; Kortunay S; Kurt E; Inan UU; Ilker SS; Basci N; Bozkurt A
Curr Eye Res; 1999 Dec; 19(6):461-4. PubMed ID: 10550786
[TBL] [Abstract][Full Text] [Related]
6. Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.
Oztürk F; Kortunay S; Kurt E; Ilker SS; Basci NE; Bozkurt A
Retina; 1999; 19(3):218-22. PubMed ID: 10380027
[TBL] [Abstract][Full Text] [Related]
7. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.
Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T
Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819
[TBL] [Abstract][Full Text] [Related]
8. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
[TBL] [Abstract][Full Text] [Related]
9. Ofloxacin penetration into the eye after intravenous and topical administration.
Fiscella RG; Shapiro MJ; Solomon MJ; Kurtz RM; Mui S; Labib S
Retina; 1997; 17(6):535-9. PubMed ID: 9428017
[TBL] [Abstract][Full Text] [Related]
10. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.
Donnenfeld ED; Perry HD; Snyder RW; Moadel R; Elsky M; Jones H
Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250
[TBL] [Abstract][Full Text] [Related]
11. Retinal safety of oral and topical ofloxacin in rabbits.
Cohen RG; Raizman M; Callina C; Lahav M
J Ocul Pharmacol Ther; 1997 Aug; 13(4):369-79. PubMed ID: 9261772
[TBL] [Abstract][Full Text] [Related]
12. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
Yu-Speight AW; Kern TJ; Erb HN
Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
[TBL] [Abstract][Full Text] [Related]
14. Penetration of gentamicin and ofloxacin in human vitreous after systemic administration.
Verbraeken H; Verstraete A; Van de Velde E; Verschraegen G
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S59-65. PubMed ID: 8871151
[TBL] [Abstract][Full Text] [Related]
15. Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection.
Chan KP; Chu KO; Lai WW; Choy KW; Wang CC; Lam DS; Pang CP
Anal Biochem; 2006 Jun; 353(1):30-6. PubMed ID: 16620758
[TBL] [Abstract][Full Text] [Related]
16. The penetration of ofloxacin into human aqueous humor given by various routes.
Hanioglu-Kargi S; Basci N; Soysal H; Bozkurt A; Gürsel E; Kayaalp O
Eur J Ophthalmol; 1998; 8(1):33-6. PubMed ID: 9590593
[TBL] [Abstract][Full Text] [Related]
17. The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin.
Oztürk F; Kurt E; Inan UU; Kortunay S; Ilker SS; Başci NE; Bozkurt A
Int J Pharm; 2000 Aug; 204(1-2):97-100. PubMed ID: 11011991
[TBL] [Abstract][Full Text] [Related]
18. Aqueous and vitreous penetration of levofloxacin after oral administration.
Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP
Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658
[TBL] [Abstract][Full Text] [Related]
19. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
20. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
Wei LC; Tsai TC; Tsai HY; Wang CY; Shen YC
Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
